Search results
A little-understood sleep disorder affects millions and has clear links to dementia – 4 questions...
The Conversation via Yahoo News· 20 hours agoThe disease mechanism is not well understood. In some cases of REM sleep behavior disorder, a clear...
The Bruins’ survival, the Maple Leafs’ heartbreak, and other final thoughts from an absurd...
The Boston Globe· 16 hours agoTied at 1-1 entering OT Saturday night, the Leafs chose an inopportune time for their five skaters...
Earnings call: Harmony Biosciences maintains strong growth, eyes future launches
Investing.com· 6 days agoHarmony Biosciences (ticker: HRMY) has reported a solid start to the year with a 30% increase in...
Trump Is Now Raging at His Own Lawyer—and Wrecking a Big MAGA Fantasy
The New Republic via Yahoo News· 5 days agoTrump also promoted a video of Fox’s Jeanine Pirro insisting that it showcases his ability to...
Alkermes plc Reports First Quarter 2024 Financial Results
WKBN 27 Youngstown· 5 days agoAlkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2024. With these new data now in hand, we plan to initiate a phase 2 study in narcolepsy type 2 in the second half of 2024.
Woman told to see doctor after dog starts acting 'weird' around her
Daily Express· 5 hours agoA woman has been left concerned by her dog's peculiar behaviour and, after seeking advice online,...
Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfront
FierceBiotech· 6 days agoHarmony Biosciences is adding a suite of epilepsy assets to its pipeline, buying Epygenix for $35 million upfront with more than $600 million in biobucks on the table. The relatively small M ...
Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 5 days agoOur commercial business is strong and Wakix continues to demonstrate durable growth now year five in...
Earnings call: Alkermes reports solid Q1 2024 results, optimistic about pipeline By Investing.com
Investing.com· 4 days agoThe neuroscience company reported net sales for VIVITROL at $97.7 million, ARISTADA at $78.9...
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 4 days agoRecent Updates Last month, Alkermes announced positive top-line data from a phase Ib study...